CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 68 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04570046
NCT04570046N/ACompleted

Retrospective Study on MR Imaging of ET and PD Patients Subjected With MRgFUS Thalamotomy

Chinese PLA General Hospital·observational·Posted Sep 30, 2020·Updated May 1, 2024

In Brief

An observational study for Movement Disorders. Completed, enrolled 68 participants across 1 site.

Detailed Summary

The technological advance of magnetic resonance-guided focused ultrasound (MRgFUS) has once again brought lesion therapy back to the clinical frontline for the treatment of movement disorder. Thus far, the safety of MRgFUS has been widely proven and has just been made available in China in late 2020. We attempted to analyze the neuroplasticity characteristics and altered neural circuit activity in patients subjected with MRgFUS thalamotomy via post-hoc retrospective analysis of archived MR imaging in our site, and to explore potential biomarkers that could be used to predict the treatment outcome.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 30, 2020
Enrollment StartDec 18, 2018
Primary CompletionAug 20, 2020
Study CompletionAug 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.8 years ago